Vol. 23 Nbr. 2, September - September 2013
> SIGN UP FREE
- Improving the quality of health care: where law, accreditation, and professionalism collide.
- Direct and enhanced disclosure of researcher financial conflicts of interest: the role of trust.
- An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
- The good, the bad, and the ugly: the unnecessarily broad impact of qui tam civil False Claims Act cases on rural health care providers.
- Challenging the FDA's authority to regulate autologous adult stem cells for therapeutic use: Celltex Therapeutics' partnership with RNL Bio, substantial medical risks, and the implications of United States v. Regenerative Sciences.
- Nanotechnology: using co-regulation to bring regulation of modern technologies into the 21st century.
- "I hate my doctor": reputation, defamation, and physician-review websites.
- A proposal for congressionally mandated federal regulation of child-directed food and beverage television advertisements to combat childhood obesity.